-+ 0.00%
-+ 0.00%
-+ 0.00%

aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate

Benzinga·11/05/2026 21:25:22
Listen to the news
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from the same period last year.